References
- Perfetto EM, Keating K, Merchant S, Nichols BR. Acute uncomplicated UTI and E. Coli resistance: implications for first-line empirical antibiotic therapy. J Manag Care Pharm. 2004;1017-25.
- Fourcroy JL, Gupta K, Hooton TM, et al. Managing acute uncomplicated cystitis in the era of antibiotic resistance. Medscape Web site; 2003. Available at: http://www.medscape.com/viewprogram/2634
- Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community acquired urinary tract infections. Ann Intern Med. 2001;13541-50.
- Gupta K, Sahm DF, Mayfield D, Stamm WE. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis. 2001;3389-94.
- Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis. 1999;29745-758.
- Bolon MK, Wright SB, Howard SG, Carmeli Y. The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported. Antimicrob Agents Chemother. 2004;481934-1940.
- Zervos MJ, Hershberger E, Nicolau DP, et al. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000. Clin Infect Dis. 2003;371643-1648.
- Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis [serial online]. November 2003. Available at: http://www.cdc.gov/ncidod/EID/vol9no11/03-0284.htm
- Hooper DC. Emerging mechanisms of fluoroquinolone resistance. Emerg Infect Dis [serial online]. March-April 2001. Available at: http://www.cdc.gov/ncidod/eid/vol7no2/hooper.htm
- Gaspari R, Bosker G. Urinary Tract Infection: Risk Stratification, Clinical Evaluation, and Evidence-Based Antibiotic Therapy—Year 2003 Update. Atlanta, GA: American Health Consultants; 2003:1-22.
- Goldstein EJ, Garabedian-Ruffalo SM. Widespread use of fluoroquinolones versus emerging resistance in pneumococci. Clin Infect Dis. 2002;351505-1511.
- Hooton TM, Levy SB. Antimicrobial resistance: a plan of action for community practice. Am Fam Physician. 2001;631087-1096.
- MetlayJP, Strom BL, Asch DA. Prior antimicrobial drug exposure: a risk factor for Trimethoprim-sulfamethoxazole-resistant urinary tract infections. J Antimicro Chemother. 2003;51963-970.
- Karlowsky JA, Thornsberry C, Jones, ME, Sahm DF. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. Clin Infect Dis. 2003:36183-187.
- Karlowsky JA, Kelly LJ, Thornsberry C, Jones, ME, Sahm DF. Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother. 2002;462540-2545.
- Institute for Clinical Systems Improvement. Uncomplicated Urinary Tract Infection in Women. Bloomington, MN: Institute for Clinical Systems Improvement; 2002:1-15.
- Brown PD, Freeman A, Foxman B. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Clin Infect Dis. 2002;341061-1066.
- Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia Coli clonal group. N Engl J Med. 2001;3451007-1008.
- Institute for Clinical Systems Improvement. Uncomplicated Urinary Tract Infection in Women. Bloomington, MN: Institute for Clinical Systems Improvement; 2004:1-21.
- National Center for Education Statistics. Total Fall Enrollment in Degree-Granting Institutions, by Attendance Status, Age, and Sex: Selected Years, 1970 to 2013. National Center for Education Statistics Web site. Available at: http://nces.ed.gov/programs/digest/d03/tables/dt176.asp
- O'Donnell JA, Gelone SP, Abrutyn E. Selecting drug regimens for urinary tract infections: current recommendations. Infect Med. 2002;1914-22.
- Miller LG, Tang AW. Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance. Mayo Clin Proc. 2004;791048-1054.
- Garrison J, Hooton TM. Fluoroquinolones in the treatment of acute uncomplicated urinary tract infections in adult women [abstract]. Expert Opin Pharmacother. 2001;21227-1237.
- Linder JA, Huang ES, Steinman MA, Gonzales R, Stafford RS. Fluoroquinolone prescribing in the United States: 1995 to 2002 [abstract]. Am J Med. 2005;118259-68.